The purpose of this study is to examine whether vitamin E (DL-alpha-tocopherol)
supplementation will reduce the progression of early atherosclerosis in healthy individuals
over 40 years of age with low-density lipoprotein (LDL) cholesterol levels greater than or
equal to 130mg/dL.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
National Institute on Aging (NIA)
Collaborator:
Hoffmann-La Roche
Treatments:
alpha-Tocopherol Tocopherols Tocotrienols Vitamin E Vitamins